SAN MARINO, Calif.
- Oct. 7, 2020
-- Global Precision Medicine Market
growth) is expected to reach the market valuation of US$ 105.64 billion by 2026 expanding at a reasonable CAGR of 9.95% during the forecast period (2021-2026) from US$ 58.66 billion in 2019. Development in precision medicine is occurring at an owing to the effectiveness of this medication. Government bodies such as research institutes and hospitals are also taking part for its development.
Healthcare is changing rapidly. Several technologies are being introduced every year to decrease the mortality rate. Currently, a transition has been witnessed from the traditional reactive medicine that was based on symptoms, diagnosis and treatment to a system that targets the disease much earlier it occurs. Precision Medicine is that new way of thinking. The major principles on which the precision medicine is based involves prediction, prevention, personalization, and participation. The growing attention toward precision medicine is directed by a fundamental shift from the 'one size fits all' paradigm for treatment of patients with conditions or predisposition to diseases. Driven by these, numerous national as well as international genome projects have been initiated to reap the benefits of precision medicine.For a detailed analysis of the automation in Precision Medicines browse through - https://univdatos.com/report/global-market-insights-on-precision-medicine-2020-2026